176 related articles for article (PubMed ID: 23810767)
1. Recombinant Mal d 1 is a reliable diagnostic tool for birch pollen allergen-associated apple allergy.
Kollmann D; Geroldinger-Simic M; Kinaciyan T; Huber H; Ebner C; Lidholm J; Bohle B
J Allergy Clin Immunol; 2013 Oct; 132(4):1008-10. PubMed ID: 23810767
[No Abstract] [Full Text] [Related]
2. Sensitization profiles in birch pollen-allergic patients with and without oral allergy syndrome to apple: lessons from multiplexed component-resolved allergy diagnosis.
Ebo DG; Bridts CH; Verweij MM; De Knop KJ; Hagendorens MM; De Clerck LS; Stevens WJ
Clin Exp Allergy; 2010 Feb; 40(2):339-47. PubMed ID: 19709127
[TBL] [Abstract][Full Text] [Related]
3. Lipid transfer protein in diagnosis of birch-apple syndrome in children.
Cudowska B; Kaczmarski M; Restani P
Immunobiology; 2008; 213(2):89-96. PubMed ID: 18241693
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Birch Pollen Immunotherapy on Apple and rMal d 1 Challenges in Adults with Apple Allergy.
van der Valk JPM; Nagl B; van Wljk RG; Bohle B; de Jong NW
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32085633
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of birch recombinant allergens (rBet v 1, profilin rBet v 2) in children with pollen-related food allergy.
Cudowska B; Kaczmarski M
Rocz Akad Med Bialymst; 2004; 49():111-5. PubMed ID: 15631325
[TBL] [Abstract][Full Text] [Related]
6. In vitro analysis of birch-pollen-associated food allergy by use of recombinant allergens in the basophil activation test.
Erdmann SM; Sachs B; Schmidt A; Merk HF; Scheiner O; Moll-Slodowy S; Sauer I; Kwiecien R; Maderegger B; Hoffmann-Sommergruber K
Int Arch Allergy Immunol; 2005 Mar; 136(3):230-8. PubMed ID: 15713985
[TBL] [Abstract][Full Text] [Related]
7. Identification of B-cell epitopes of Bet v 1 involved in cross-reactivity with food allergens.
Klinglmayr E; Hauser M; Zimmermann F; Dissertori O; Lackner P; Wopfner N; Ferreira F; Wallner M
Allergy; 2009 Apr; 64(4):647-51. PubMed ID: 19154550
[TBL] [Abstract][Full Text] [Related]
8. Allergy to apple cultivars among patients with birch pollinosis and oral allergy syndrome.
Wagner A; Szwed A; Buczyłko K; Wagner W
Ann Allergy Asthma Immunol; 2016 Oct; 117(4):399-404. PubMed ID: 27593099
[TBL] [Abstract][Full Text] [Related]
9. Successful sublingual immunotherapy with birch pollen has limited effects on concomitant food allergy to apple and the immune response to the Bet v 1 homolog Mal d 1.
Kinaciyan T; Jahn-Schmid B; Radakovics A; Zwölfer B; Schreiber C; Francis JN; Ebner C; Bohle B
J Allergy Clin Immunol; 2007 Apr; 119(4):937-43. PubMed ID: 17204315
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric analysis of in vitro activated basophils, specific IgE and skin tests in the diagnosis of pollen-associated food allergy.
Ebo DG; Hagendorens MM; Bridts CH; Schuerwegh AJ; De Clerck LS; Stevens WJ
Cytometry B Clin Cytom; 2005 Mar; 64(1):28-33. PubMed ID: 15668987
[TBL] [Abstract][Full Text] [Related]
11. Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.
Geroldinger-Simic M; Kinaciyan T; Nagl B; Baumgartner-Durchschlag U; Huber H; Ebner C; Lidholm J; Bartel D; Vieths S; Jahn-Schmid B; Bohle B
J Allergy Clin Immunol; 2013 Jan; 131(1):94-102. PubMed ID: 22921871
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges.
Bolhaar ST; Tiemessen MM; Zuidmeer L; van Leeuwen A; Hoffmann-Sommergruber K; Bruijnzeel-Koomen CA; Taams LS; Knol EF; van Hoffen E; van Ree R; Knulst AC
Clin Exp Allergy; 2004 May; 34(5):761-9. PubMed ID: 15144469
[TBL] [Abstract][Full Text] [Related]
13. Allergen immunotherapy for birch-apple syndrome: what do we know?
Incorvaia C; Ridolo E; Mauro M; Russello M; Pastorello E
Immunotherapy; 2017 Nov; 9(15):1271-1278. PubMed ID: 29130794
[TBL] [Abstract][Full Text] [Related]
14. Anaphylactic versus mild reactions to hazelnut and apple in a birch-endemic area: different sensitization profiles?
Le TM; van Hoffen E; Lebens AF; Bruijnzeel-Koomen CA; Knulst AC
Int Arch Allergy Immunol; 2013; 160(1):56-62. PubMed ID: 22948203
[TBL] [Abstract][Full Text] [Related]
15. Recombinant Mal d 1 facilitates sublingual challenge tests of birch pollen-allergic patients with apple allergy.
Kinaciyan T; Nagl B; Faustmann S; Kopp S; Wolkersdorfer M; Bohle B
Allergy; 2016 Feb; 71(2):272-4. PubMed ID: 26443126
[TBL] [Abstract][Full Text] [Related]
16. Clinical benefit of component-resolved diagnosis in Japanese birch-allergic patients with a convincing history of apple or peach allergy.
Shirasaki H; Yamamoto T; Abe S; Kanaizumi E; Kikuchi M; Himi T
Auris Nasus Larynx; 2017 Aug; 44(4):442-446. PubMed ID: 27816237
[TBL] [Abstract][Full Text] [Related]
17. Recombinant birch allergens (Bet v 1 and Bet v 2) and the oral allergy syndrome in patients allergic to birch pollen.
De Amici M; Mosca M; Vignini M; Quaglini S; Moratti R
Ann Allergy Asthma Immunol; 2003 Nov; 91(5):490-2. PubMed ID: 14692434
[TBL] [Abstract][Full Text] [Related]
18. IgE-blocking antibodies following SLIT with recombinant Mal d 1 accord with improved apple allergy.
Sánchez Acosta G; Kinaciyan T; Kitzmüller C; Möbs C; Pfützner W; Bohle B
J Allergy Clin Immunol; 2020 Oct; 146(4):894-900.e2. PubMed ID: 32259540
[TBL] [Abstract][Full Text] [Related]
19. Birch pollen-related food allergy: clinical aspects and the role of allergen-specific IgE and IgG4 antibodies.
Geroldinger-Simic M; Zelniker T; Aberer W; Ebner C; Egger C; Greiderer A; Prem N; Lidholm J; Ballmer-Weber BK; Vieths S; Bohle B
J Allergy Clin Immunol; 2011 Mar; 127(3):616-22.e1. PubMed ID: 21251701
[TBL] [Abstract][Full Text] [Related]
20. Colonoscopic allergen provocation test with rBet v 1 in patients with pollen-associated food allergy.
Pickert CN; Lorentz A; Manns MP; Bischoff SC
Allergy; 2012 Oct; 67(10):1308-15. PubMed ID: 22913618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
